NEWS AND EVENTS
MD Anderson and Deerfield Management create Vescor LLC to develop novel therapeutics based on inhibiting autophagy for treatment of specific cancers
Pioneering Drug Discovery Company Bridge Medicines Launched to Advance Promising Early Technologies in Major Academic Institutions through Human Proof of Concept
Deerfield Announces Strategic Collaboration with Peking Union School of Public Health to Advance Healthcare in China
Deerfield Leads Series D Investment in SentreHEART
Deerfield Invests in FOG Pharmaceuticals, Inc.
Deerfield Management Company Completes Sale of Veterinary Practice Partners to Pamlico Capital
Deerfield Announces Lead Investment in Visionary Anti-Fibrotic Company Blade Therapeutics
Deerfield Supports Patient Care Advancing Ophthalmology Company Graybug Vision
Deerfield Invests $80 million in Leading Population Health Services Company
Deerfield Leads $34 Million Investment in Lumos Pharma
Deerfield Invests in Potential Treatment Transforming Electrophysiology Company
Deerfield Invests in Transformative Microbiome Platform
Deerfield Management and Oxeon Unlock the Power of Women in the Boardroom
Deerfield Advances Healthcare Through the Publication of Novel Findings
Deerfield Leads Investment in Advantia Health
Deerfield Announces Partnership with Recovery Centers of America
Deerfield Leads Series 1-A financing for Hallux
Deerfield Invests in Series A for Aziyo
Deerfield Management Announces Partnership with Gregory Sorensen and Deerfield Imaging
Deerfield Makes $50 Million Commitment to AAC Holdings to Expand Clinical Care and Treatment with Additional $50 Million Incremental Facility
Deerfield Leads Funding in Creation of Akari Therapeutics
Deerfield Invests in Headspace
Deerfield Invests $20 million in Editas Medicine
Deerfield Invests in Rhythm Metabolic
Deerfield Launches $550 Million Healthcare Venture-Capital Fund
How to End the Regulatory Slowdown for New Antibiotics - WSJ
Deerfield Invests in TriNetX
Deerfield Invests in CytomX Therapeutics
Deerfield Invests in NeoChord
Deerfield Announces a $300 million commitment to create and build Aralez Pharmaceuticals Ltd.
Deerfield supports EuropaBio selected Most Innovative European Biotech SME Awards
Deerfield Commits to Invest $10 million in Vital Access
Deerfield Invests in Shockwave Medical
Deerfield Leads Series B Preferred Financing for Cureatr
Deerfield Invests $48 million in Trinity Biotech
Deerfield and EuropaBio Publish a Report on Regulatory and HTA Scientific Advice for Small and Medium Enterprises
Deerfield Provides Debt Facility to Depomed
Improving Pharmaceutical Innovation by Building a More Comprehensive Database on Drug Development and Use (Health Affair: Feb 2015)
Deerfield Institute Announces the Publication of “Improving Pharmaceutical Innovation by Building a More Comprehensive Database on Drug Development and Use” in the February issue of Health Affairs Journal”
Deerfield Management Company Invests in SteadyMed Ltd.
Deerfield Finances Pioneer in 3D Printing for Pharmaceuticals
Deerfield Management Company Invests in REGENXBIO Inc.
Deerfield Invests in Essa Pharmaceuticals
Deerfield Invests in Global Blood Therapeutics
Deerfield Invests in Audentes Therapeutics
Deerfield Invests in Conventus Orthopaedics, Inc.
Deerfield Management Company Invests $50 million in Alimera Sciences, Inc.
Deerfield Management Company Announces a $5 million investment in MedAvail Technologies, Inc.
Deerfield Management Company Announces a $125 million Term Sheet with SHINE Medical Technologies, Inc.
Deerfield Management Announces a $125 million Facility with Aerie Pharmaceuticals
Deerfield Announces a $4.5 million Venture Capital Investment in Epion Health
Deerfield Management Company Announces up to a $60 million Facility with KemPharm, Inc.
Deerfield Invests in Spark Therapeutics
Deerfield Invests in Proteon Therapeutics, Inc.
Deerfield Invests $27.5mm in OMNIlife science, Inc.
Deerfield Announces New $1.6 Billion Private Investment Fund to Advance Healthcare
Deerfield Announces a $35 million Investment Commitment for Cytomedix, Inc.
Deerfield Announces $15 Million Investment in Wellfount
Deerfield Provides up to $250 million in Acquisition Financing to Horizon Pharma
Deerfield Announces up to a $50 million Investment in Alphatec Spine
Deerfield Provides a flexible financing of up to $100 million to Infinity Pharmaceuticals
Deerfield Announces up to $50 Million Investment in Fidelis SeniorCare
Deerfield Invests $160 Million in MannKind Corporation
Deerfield Announces $35 Million Investment in WorldOne
Deerfield Announces $30 Million Investment in Discovery Labs
Deerfield Announces Financing Transaction with Flamel Technologies
Deerfield Completes $20.5 Million Financing in Pacific Biosciences
Deerfield Management Announces Appointment of Jonathan S. Leff as Partner and Chairman of the Deerfield Institute
Deerfield Provides a flexible $50 million facility to MAKO Surgical
Deerfield Divests topical herpes drug Denavir to Renaissance Pharmaceuticals
© 2017 Deerfield. All rights reserved |